GLIOBLASTOMA (GBM)
Clinical trials for GLIOBLASTOMA (GBM) explained in plain language.
Never miss a new study
Get alerted when new GLIOBLASTOMA (GBM) trials appear
Sign up with your email to follow new studies for GLIOBLASTOMA (GBM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Fewer radiation sessions could ease brain tumor treatment burden
Disease control Not yet recruitingThis pilot study tests a new radiation schedule for glioblastoma, a serious brain cancer. Instead of standard daily treatments over many weeks, patients receive a higher dose each day for fewer total sessions, combined with the chemotherapy drug temozolomide. The study aims to se…
Matched conditions: GLIOBLASTOMA (GBM)
Phase: NA • Sponsor: Hospital do Coracao • Aim: Disease control
Last updated Jun 23, 2026 20:32 UTC
-
New hope for glioblastoma: drug combo targets recurrent tumors
Disease control Not yet recruitingThis early-phase trial tests a new drug, STAR-001, combined with the diuretic spironolactone in about 68 people whose glioblastoma has returned after initial treatment. The goal is to see if the combination is safe and can shrink tumors. Participants receive STAR-001 by IV twice …
Matched conditions: GLIOBLASTOMA (GBM)
Phase: PHASE1, PHASE2 • Sponsor: Starlight Therapeutics Inc. • Aim: Disease control
Last updated Jun 22, 2026 11:54 UTC
-
New hope for deadly brain cancer? early trial launches
Disease control Not yet recruitingThis early-stage study tests a new drug called FZ-AD005 in 40 people with aggressive brain tumors (high-grade glioma) that have come back or not responded to treatment. The drug is designed to target and kill cancer cells while sparing healthy ones. The main goals are to find the…
Matched conditions: GLIOBLASTOMA (GBM)
Phase: PHASE1 • Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC
-
Could a shingles vaccine help fight deadly brain cancer?
Disease control Not yet recruitingThis study tests whether adding a shingles vaccine and, for some patients, specially grown immune cells (CMV-specific T cells) to standard surgery, radiation, and chemotherapy can help people with glioblastoma live longer. About 230 adults with this aggressive brain cancer will t…
Matched conditions: GLIOBLASTOMA (GBM)
Phase: PHASE4 • Sponsor: University Hospital, Essen • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
Supercharged immune cells take on deadly brain tumors
Disease control Not yet recruitingThis early-phase study tests a new type of cell therapy (Meta10-EGFRvIII CAR-T) for people whose glioblastoma brain cancer has come back. The therapy uses the patient's own immune cells, modified to better find and attack cancer cells. The main goal is to check safety, and resear…
Matched conditions: GLIOBLASTOMA (GBM)
Phase: EARLY_PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC
-
New program aims to ease the heavy burden on brain injury caregivers
Symptom relief Not yet recruitingThis study tests a program to help relatives of people with serious brain conditions like stroke, brain tumor, or traumatic brain injury. The program offers step-by-step support, starting with basic information and adding more help if needed, such as talks with nurses or better c…
Matched conditions: GLIOBLASTOMA (GBM)
Phase: NA • Sponsor: Rigshospitalet, Denmark • Aim: Symptom relief
Last updated Jun 15, 2026 19:08 UTC
-
New microscope gadget aims to sharpen brain tumor surgery
Knowledge-focused Not yet recruitingThis study tests a special add-on for surgical microscopes that makes brain tumor tissue glow during surgery. About 37 adults with suspected high-grade glioma will take part. Surgeons will rate how well the tool shows the tumor and the quality of the images. The goal is to see if…
Matched conditions: GLIOBLASTOMA (GBM)
Sponsor: Leica Microsystems (Schweiz) AG • Aim: Knowledge-focused
Last updated Jun 22, 2026 11:54 UTC